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SUMMARY
The beneficial properties of polyphenols are widely recognized, and polyphenol-rich 
olive oil, which is part of the typical Mediterranean diet, has been identified as having pos-
itive health effects. However, over the past decade, olive leaves have been discovered as 
an alternative polyphenol-rich source. This is particularly interesting in the context of the 
growing interest in functional foods, as well as in terms of the management of biological 
waste, including olive leaves that are left over from the production of olive oil. Previous 
studies on olive leaves confirmed that they have a high phenolic content, which explains 
their previously described strong antibacterial, antimicrobial and antiviral activity. There-
fore, the major aim of our work is to comprehensively determine olive leaf phenolic content 
in cultivars Istarska bjelica, Leccino and Buža as a natural source of bioactive compounds 
suitable for daily consumption in the form of infusion. For this purpose, we examined the 
influence of olive leaf cultivar, maceration time and temperature on the phenolic compo-
sition of final infusions. Phenolic compounds were analysed by liquid chromatography 
(LC) coupled to a triple quadrupole mass spectrometer (LC-QQQ). As expected, the results 
indicate the significant influence of not only the olive cultivar but also of maceration pa-
rameters on the qualitative and quantitative phenolic composition. The highest phenolic 
compound content was obtained in the infusion of Istarska bjelica leaves after 15 min of 
maceration. However, the Buža olive leaf infusion had the most diverse phenolic compo-
sition. Furthermore, we designed several functional olive leaf infusion mixtures with phe-
nolic compositions adjusted based on the desired health effect. The results show the role 
of phenolic composition adjustment in the development and improvement of the quality 
of functional olive leaf infusions.
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INTRODUCTION
Polyphenols, as plant secondary metabolites, show a high degree of structural diversi-
ty. They are present and stored in plant tissues in the form of different derivatives, mainly 
as sugar O-glycosides (1). Glycosylation ensures their structural stability during storage in 
the vacuoles and chloroplasts of plants.
Olive oil is considered to be outstanding due to its high polyphenolic content, and it is 
well-known for its nutritive and health-promoting potential (2). In addition to the olive fruit, 
from which olive oil is derived, olive leaves are also a rich source of phenolic compounds 
(3). However, olive leaves have not yet been sufficiently exploited in medical applications 
as a source of beneficial phenolics. Interestingly, olive leaves are traditionally trimmed from 
olive trees, but are not used afterwards, typically ending up as biological waste. The ex-
ploitation of olive leaves as a starting raw material in the production of functional food or 
other medical products may thus improve biological waste management.
Data from a number of studies suggest that olive leaf extracts reduce the risk of cardio- 
vascular disease (CVD) due to their anti-atherosclerotic, hypotensive, antioxidant, anti-in-
flammatory and hypocholesterolaemic effects (4). The phenolic compounds from leaves also 
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possess antimicrobial (2) and neuroprotective activity (5). Nev-
ertheless, limited data on the effects of olive leaf polyphenols 
in humans is available in the scientific literature. Still, some ran-
domized clinical studies show that olive leaf polyphenols are 
favourable modulators of blood pressure, plasma lipid profiles 
(4) and insulin sensitivity in overweight people (6).
The colorimetric Folin-Ciocalteu assay is the most used 
and rapid quantitative technique for determining the content 
of total polar phenolics. This method has been used previous-
ly for olive leaf analyses (7). However, colorimetric methods 
provide information only about total phenolic content, with-
out giving any details about their characterization. In order 
to obtain a detailed representation of the phenolic compo-
sition of olive leaves, chromatographic methods are used in 
combination with various detectors. High-performance liquid 
chromatography (HPLC) is the most widely used method for 
analysing phenolic compounds. However, for a detailed de-
termination of the phenolic composition, as well as all possi-
ble phenolic derivatives, mass spectrometry (MS) techniques 
are increasingly employed. MS provides higher selectivity and 
sensitivity than other methods and has been shown to be one 
of the most effective techniques in biomedical research, espe-
cially for the analysis of complex biological matrices (8).
Therefore, in this paper we determined the phenolic com-
position of three olive leaf cultivars (i.e. Istarska bjelica, Lec-
cino and Buža) by liquid chromatography (LC) coupled to a 
triple quadrupole mass spectrometer (QQQ). The obtained 
data were used to design functional olive leaf infusions, be-
cause this form of preparation is suitable for daily consump-
tion and has been accepted in many cultures. Additionally, 
water is a cheap and non-hazardous polar solvent. By using 
a mixture design approach, herein we propose several differ-
ent mixtures of analysed olive leaf cultivars with the desired 
phenolic content assumed to yield a specific biological effect.
MATERIALS AND METHODS
Reagents and chemicals
The 2,5-dihydroxybenzoic acid (2,5-DHBA), 3,4-dihydrox-
ybenzoic acid (3,4-DHBA), 4-hydroxybenzoic acid (pHBA), 
3-hydroxytyrosol, apigenin, caffeic acid, chrysin, quercetin, 
naringenin, diosmetin, rutin, luteolin, luteolin-7-O-glucoside, 
p-coumaric acid, oleuropein and tyrosol were all from Sig-
ma-Aldrich (Merck, St. Louis, MO, USA). Ferulic acid was pur-
chased from Extrasynthese (Genay, France). Apigenin-7-O-glu-
coside and verbascoside were obtained from HWI Analytik 
GmbH (Rülzheim, Germany). Gallic acid was obtained from 
Alfa Aesar (Thermo Fisher Scientific, Waltham, MA, USA).
Chemical reagents methanol (LC-MS purity) and acetoni-
trile (LC-MS purity) were purchased from Honeywell Research 
Chemicals (Bucharest, Romania). Formic acid (LC-MS purity) 
was obtained from Sigma-Aldrich, Merck. Milli-Q water was 
obtained using a Milli-Q water purification system (<0.058 
μS/cm, Mili-Q model Pacific TII 12; Barnstead™, Thermo Fish-
er Scientific).
Olive leaf extraction procedures
Olive leaves of Istarska bjelica, Leccino and Buža varieties 
were obtained from the same olive plantation (45°19'53.6"N, 
13°35'04.8"E) in Novigrad, Istria, Croatia (April 2017). Samples 
were dried and stored in the dark at room temperature until 
analysis. Simulating household conditions, the olive leaf in-
fusions were prepared from olive leaves roughly ground in a 
mortar. For optimization of extraction procedure, olive leaves 
from Istarska bjelica cultivar were used. In this process, 0.2 g 
of ground olive leaves were macerated in 20 mL of water that 
was heated to three different temperatures (80, 90 and 100 °C). 
Leaves were macerated in hot water for 1, 5, 10, 15 or 20 min. 
Organic extraction was carried out by adding 4 mL of methanol 
to 50 mg of chopped leaves. Afterwards, samples were sonicat-
ed in an ultrasonic bath (Sonorex Digitec, Bandelin electronic 
GmbH & Co. KG, Berlin, Germany) for 10 min at a constant tem-
perature of 25 °C. All extracts were filtered using Chromafil® 
cellulose acetate microfilters (0.45 µm, 25 mm; Macherey-Nagel 
GmbH & Co. KG, Düren, Germany) before analysis.
LC-QQQ analysis
An Agilent 1260 series HPLC chromatograph equipped with 
a degasser, binary pump, auto-sampler and column oven cou-
pled to an Agilent 6460 triple quadrupole mass spectrometer 
equipped with Jet Stream electrospray (AJS ESI) source was 
used for quantitative analysis and the data was processed with 
MassHunter workstation software v. B.07.00 (Agilent Technolo-
gies, Inc., Palo Alto, CA, USA).
For chromatographic separation of phenolic compounds, 
two methods were developed. In the first method, chromato-
graphic analyses were carried out on Zorbax SB-C18, Rapid Res-
olution HT, 60 000 kPa column (2.1 mm i.d.×50 mm, particle size 
1.8 µm; Agilent Technologies, Inc.). The mobile phase consisted 
of: 0.1 % formic acid in Milli-Q water (A) and 0.1 % formic acid 
in acetonitrile (B). The gradient elution was modified as follows: 
0-0.9 min linear gradient from 1 to 10 % B, 0.9-3 min from 10 to 
20 % B, 3-4.5 min from 20 to 25 % B, 4.5-6 min from 25 to 30 % 
B, 6-7.5 min at 30 % B, 7.5-9 min from 30 to 90 % B, 9-9.30 min at 
90 % B, 9.30-9.60 min from 90 to 10 % B and 9.60-15 min from 
10 to 1 % B. Holding time was set to 2 min to equilibrate the sys-
tem. The flow rate was 0.33 mL/min. The column temperature 
was maintained at 30 °C. The sample injection volume was 2.5 
µL. For MS, the parameters were set as follows: capillary voltage 
was 3.5 kV in both positive and negative mode, nozzle voltage 
0.5 kV, ion source temperature was set to 300 °C, gas flow was 5 
L/min, nebulizer pressure 310 kPa, drying gas temperature 250 
°C and sheath gas flow 11 L/min. Nitrogen was used as collision 
gas and collision energies were from 0 to 40 V (Table 1).
In the second method, tyrosol was analysed using the same 
chromatographic column and mobile phases, but with differ-
ent gradient elution: 0-0.1 min linear gradient from 1 to 10 % 
B, 0.1-13.39 min from 10 to 90 % B, 12.39-14.59 min from 90 to 
10 % B, from 14.59-16 min from 10 to 1 % B and 16-20 min at 1 
% B. Holding time was set to 4 min. The flow rate was 0.1 mL/
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min. The column oven temperature was maintained at 30 °C. 
The sample injection volume was 10 µL. For MS, the parameters 
were set as follows: capillary voltage was 4 kV in both positive 
and negative mode, nozzle voltage 0.5 kV, ion source tempera-
ture set to 300 °C, gas flow 10 L/min, nebulizer pressure 241 kPa, 
drying gas temperature 250 °C and sheath gas flow 11 L/min. 
Nitrogen was used as collision gas and collision energies were 
from 6 to 50 V (Table 1).
To establish the calibration curves, reference phenolic com-
pounds were dissolved in methanol and diluted to the appro-
priate concentrations. For quantitative analysis, 15 different 
concentrations were made for each standard and the linearity 
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3-Hydroxytyrosol - 152.9 100 95.0*94.8
18
20 756.9 18.41 0.1-2.5 0.994 0.080 0.243 1.73
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Naringenin - 270.9 140 151.0*118.9
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61.5 -19.73 0.5-5 0.993 0.962 3.206 1.74
Slope and intercept were determined from the calibration curve (Y=ax+b). Mode=ionization mode, Frag=fragmentor, CE=collision energy, 
R2=coefficient of determination, LOD=limit of detection, LOQ=limit of quantification, RT=retention time 
*quantification transition
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ranges of their calibration curves are shown in Table 1. All stand-
ard samples were injected in triplicates. Calibration curves were 
constructed using linear regression and were not forced to pass 
through zero. Also, a 1/x statistical weight was applied to obtain 
the most reliable calibration curves for all the phenolics. The cali-
bration curve ranges were obtained based on the linearity of 
the responses of each individual metabolite (Table 1). The limit 
of detection (LOD) and limit of quantification (LOQ) were deter-
mined using quantifier transition according to the guidelines of 
the International Council on Harmonization (ICH) (9).
Statistical data processing and design of the experiment
Statistical data processing was performed using Design-Ex-
pert software v. 10.0.3.1 (10). A specialized form of response sur-
face methodology in Design-Expert software was used for de-
signing the mixture formulation. This method established the 
surface model, estimated all desired components in the mix-
ture and optimized the ratios of individual olive leaf varieties 
in the final mixture according to the targeted phenolic compo-
nents. Olive leaf mixtures were designed according to the pro-
posed ratio for each olive leaf cultivar given in the experimen-
tal design. Mixtures were prepared with the same optimized 
extraction method that was used for the characterization of 
single olive leaf cultivar.
RESULTS AND DISCUSSION
The phenolic compositions of olive leaf infusions from three 
olive varieties were analysed using an LC-QQQ method. Firstly, 
maceration time and temperature were optimized to obtain the 
highest mass fraction of phenols and to retain the maximum 
possible diversity of phenolic composition in the olive leaf infu-
sions. Three different temperatures (80, 90 and 100 °C) and five 
different maceration times (1, 5, 10, 15 and 20 min) were evalu-
ated in the preparation of olive leaf infusions from the cultivar 
Istarska bjelica. Total phenolic content was determined by sum-
ming up the mass fractions of all detected individual polyphe-
nols. The results revealed that temperature and time had an ev-
ident effect on the mass fraction of extracted phenols (Fig. 1). 
The highest mass fraction was obtained after 15 min of macer-
ation with the starting water temperature of 100 °C.
Optimal maceration parameters were applied for the prepa-
ration of infusions with the other two leaf varieties: Leccino and 
Buža. The LC-QQQ analysis of olive leaf infusions revealed dif-
ferent phenolic compositions of each analysed olive leaf culti-
var. The infusion of Istarska bjelica olive leaves had the highest 
total phenolic mass fraction on dry mass basis (3.9 mg/g), with 
oleuropein as the most dominant compound, followed by ver-
bascoside, rutin, luteolin-7-O-glucoside and 3-hydroxytyrosol 
(Fig. 2). In all tested samples, oleuropein was the major phenol-
ic compound. However, its mass fraction, as well as the pres-
ence of other phenolic compounds, was different in each olive 
leaf cultivar. Leccino and Buža had lower mass fractions of total 
phenolics than Istarska bjelica, but showed a greater variety in 
the number of unique phenolic compounds. Interestingly, olive 
leaf infusions from Buža had two specific phenolic compounds, 
namely quercetin and diosmetin, that were not detected in the 
infusions produced from the other leaves.
Phenolic fractions obtained by using the optimized meth-
od for infusion preparation were compared with the ones in the 
extracts of olive leaves produced with organic solvent (meth-
anol). In the organic extraction-based procedure, a high yield 
of phenolic compounds was achieved. Additionally, extraction 
was enhanced by treating the infusion with ultrasound for 10 
min (which was shown to be the longest ultrasound exposure 
time for high phenolic yield without causing phenol degra-
dation). In Fig. 3 water-based and organic solvent-based ex-
tractions are compared. Fig. 3a shows total mass fractions of 
phenolic compounds extracted from three different olive leaf 
varieties using these two methods. Although methanol-based 
extraction provided higher phenolic mass fractions in the final 
product, water-based extraction provided rather good results, 
containing on average 41.83 % of the total phenolics found 
in the extracts produced with methanol extraction. Further-
more, Fig. 3b shows the mass fractions of the two main com-
pounds quantified in olive leaves, rutin and oleuropein, after 
the two different extraction procedures. The results show that 
water-based extraction yielded extracts with higher rutin mass 
fractions in all cases regardless of the olive cultivar. This was ex-
pected, as rutin is a hydrophilic molecule with a logP=-0.87 (11), 
where P is a partition coefficient. In contrast, oleuropein mass 

























Fig. 1. Total phenolic mass fractions (calculated as the sum of all ana-
lysed phenols; mean value±standard deviation (S.D.)) in the infusions 
of Istarska bjelica olive leaves after extraction at: a) different temper-
atures, and b) different times of maceration 
a)
b)
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lipophilicity of these molecules (logP=0.11) (11). These results 
support the use of the herein presented method for infusion 
production, as they reveal that this method provides good phe-
nolic yield and can be used to extract large amounts of hydro-
philic compounds.
Based on these findings, we designed formulations for 
three different functional olive leaf infusions by using mixture 
design in Design-Expert software (10). The idea was to prepare 
infusions with different biological activities: mix 1 with a po-
tential positive effect on cardiovascular system, mix 2 with a 
potential positive effect on reducing diabetes mellitus risk, and 
mix 3 with a potential antimicrobial activity (Fig. 4). The three 
olive varieties (Istarska bjelica, Leccino and Buža) analysed in 
this study were chosen as components for the formulations, 
and the desired biological effects were adjusted according to 
the specific phenolic compounds previously identified as bio-
actives in certain biological processes.
The first mixture was designed as a functional infusion with 
positive effects on the cardiovascular system. CVDs have always 
been among the most common causes of death worldwide. 
They include a number of pathological states that involve car-
diac muscles or blood vessels (12). So far, a number of papers 
have reported that extra virgin olive oil polyphenols have pos-
itive effects on CVD. These polyphenols have been found to 
modulate many CVD risk factors, including inflammation (13), 
blood pressure (14), and cholesterol levels (15). George et al. 
(16), for example, analysed the results of 26 such studies and 
concluded that the intake of olive oil with high polyphenol con-
tent aids in the reduction of CVD risks, particularly those related 
to cholesterol and oxidative stress. Our focus was on atheroscle-
rosis, which is characterized by inflammation in blood vessels 
(17,18). Indeed, polyphenols can modulate atherosclerosis 
risk due to their significant antioxidant activity, which is cor-
related with their structure. Moreover, they modulate cell-sig-
nalling cascades by blocking nuclear factor kappa B, which is 
involved in inflammation. Lastly, they have been found to in-
fluence the amount of T lymphocytes and monocytes, which 
bind to the endothelium after blood vessel damage has oc-
curred and which can improve the functioning of endothelia 
(17). Previous studies examined particular roles of 3-hydroxy-
tyrosol, oleuropein and tyrosol in the prevention of atheroscle-
rosis (18). These studies are the basis for our first design, which 
was carried out using 3-hydroxytyrosol, ferulic acid, oleuropein, 
































































Fig. 2. Mass fractions of: a) total phenols (calculated as the sum of all 
analysed phenols; mean value±S.D.), and b) six main phenols (mean 
value±S.D.) in infusions of Istarska bjelica, Leccino and Buža olive 
leaves
Fig. 3. Mass fractions of: a) total phenols (calculated as the sum of all 
analysed phenols; mean value±S.D.), and b) of rutin and oleuropein 
(mean value±S.D.) in olive leaf infusions of three different olive culti-
vars after extractions with methanol and water
a) a)
b) b)
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were added due to their strong antioxidant and anti-inflam-
matory properties. Indeed, a clinical trial confirmed that feru-
lic acid has a high potential to reduce CVD risk factors, as it is 
believed to improve lipid profiles in blood vessels and to lower 
oxidative stress level (19). Also, it has been shown that ferulic 
acid might influence endothelium-dependent myocardial re-
laxation, suggesting that it benefits the cardiovascular system 
in terms of cardiac muscles as well as blood vessels (20). Querce-
tin has been shown to reduce systolic blood pressure but does 
not seem to have any other known effects in the prevention 
of CVD (21). Leading bioactives were tyrosol and oleuropein, 
so they were chosen as the most important responses in the 
final formulation. Tyrosol was chosen due to its proven inhib-
itory effect on arachidonic acid production, which lowers the 
amounts of inflammatory response mediators (22) and inhibits 
homocysteine-induced endothelial cell adhesion (23). Oleuro-
pein was chosen due to its ability to modulate different pro-
cesses in atherosclerosis development, such as the expression 
of endothelial adhesion molecules (24), inhibition of Toll-like 
receptors (25), and proliferation of smooth muscle cells (26). 
The final formulation for the first infusion contained 23.8 % Is-
tarska bjelica, 46.0 % Buža, and 30.2 % Leccino (Fig. 4a). For ty-
rosol and oleuropein, as the most important components, the 
predicted mass fractions in the final mixture were 0.08 and 0.71 
mg/g, respectively (Fig. 5).
In 1992, Gonzalez et al. (27) were the first to notice the 
protective role of olive leaf polyphenols in diabetes, and they 
opened the area of research on the analyses of metabolism 
routes of these extracts. Wainstein et al. (28) confirmed that ol-
ive leaves can normalise glucose levels in individuals with di-
abetes. Another trial revealed that olive leaf polyphenol sup-
plementation can improve insulin sensitivity and pancreatic 
β-cell secretory capacity (6). In light of this information, we de-
signed the second mixture to be a functional infusion for the 
reduction of diabetes mellitus risk. The mixture was designed 
by choosing 2,5-DHBA, 3,4-DHBA, diosmetin, luteolin-7-O-glu-
coside, rutin, oleuropein, quercetin and 3-hydroxytyrosol as re-
sponses. 2,5-DHBA, also called gentisic acid, is one of the sialic 
acid derivatives that was shown to inhibit the glucose autox-
idation-mediated atherogenic modification of low-density li-
poproteins (29). 3,4-DHBA was shown to have a high poten-
tial for diabetes control. For example, Harini and Pugalendi (30) 
compared the antihyperglycemic effects of 3,4-DHBA with the 
known drug glibenclamide, and the results obtained for both 
compounds were highly comparable. Diosmetin was previous-
ly described as a hypoglycemic agent from the plant Anoda 
cristata (31), so we included it as a response in our research. 
Luteolin-7-O-glucoside was also chosen as it improves blood 
glucose, HbA1c, insulin and homeostatic model assessment of 
insulin resistance (HOMR-IR) levels (32). Moreover, rutin low-
ers the plasma glucose levels in diabetes-induced mice, stim-
ulates glucose uptake, protects pancreatic cells, and activates 
liver enzymes that are involved in gluconeogenesis and other 
metabolic pathways associated with lipids (33,34). Oleuropein 
was confirmed as a desired polyphenol of high importance in 
Fig. 4. Contour plots for designed functional infusion mixtures: a) mix 
1 with a potential positive effect on cardiovascular system, b) mix 2 
with a potential positive effect on reducing diabetes mellitus risk and 
c) mix 3 with a potential antimicrobial activity
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this mixture as per previous reports in which it was shown that, 
along with 3-hydroxytyrosol, it might exert a significant hypo-
glycaemic effect. Quercetin can inhibit cytokine-induced cell 
damage of pancreatic β-cells (35), which was also confirmed 
in in vivo studies on rats with induced diabetes (36). Lastly, 
3-hydroxytyrosol was chosen as the most important compo-
nent in the final mixture since it was previously proposed as 
a pharmaceutical product for metabolic syndrome treatment. 
Indeed, its role in the downregulation of the sterol regulato-
ry element-binding transcription factor 1c/fatty acid synthase 
(SREBP–1c/FAS) pathway is essential for this purpose (37). Fur-
thermore, 3-hydroxytyrosol demonstrated usefulness in a num-
ber of pathological states that occur with diabetes mellitus (38). 
For example, it has been shown that 3-hydroxytyrosol can be 
neuroprotective (39). Therefore, the proposed mixture for the 
second infusion, which was designed to have a positive effect 
on the reduction of diabetes mellitus risk, was 29.9 % Istarska 
bjelica, 37.0 % Buža, and 33.1 % Leccino (Fig. 4b). The predicted 
mass fractions of 3-hydroxytyrosol and oleuropein in the mix-
ture were 0.17 and 0.81 mg/g, respectively (Fig. 6).
Fig. 5. 3D response surface plots illustrating the effect of olive cultivar in olive leaf infusion mixtures on: a) tyrosol and b) oleuropein mass 
fractions. Tyrosol and oleuropein were chosen as the most important compounds in mix 1 with possible positive effects on the cardiovascular 
system. Values in squares are the predicted mass fractions of tyrosol and oleuropein in mix 1 
Fig. 6. 3D response surface plots illustrating the effect of olive cultivar in olive leaf mixtures on: a) 3-hydroxytyrosol, and b) oleuropein mass frac-
tions. 3-Hydroxytyrosol and oleuropein were chosen as the most important responses in mix 2 with possible effect on reducing diabetes mellitus 
risk. Values in squares are the predicted mass fractions of 3-hydroxytyrosol and oleuropein in mix 2 
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In addition to their beneficial effects on human health, 
polyphenols can be exploited in the food industry as antimi-
crobial ingredients. For example, olive leaf extracts are a nat-
ural preservative (40,41). Liu et al. (42) reported that olive leaf 
extracts can inhibit the growth of Listeria monocytogenes, 
Escherichia coli O157:H7, and Salmonella Enteritidis; they also 
proposed 62.5 mg/mL as an effective antibacterial concen-
tration. Therefore, the third mixture investigated in the pres-
ent study was an antimicrobial mix ture with preferable re-
sponses apigenin-7-O-glucoside, caffeic acid, naringenin, 
Table 2. Mass fractions of phenolic compounds in three functional olive oil infusions obtained by use of mixture design in Design-Expert soft-
ware (10)
Phenolic compound



































Gallic acid 0.0007±0.0001 0.0067±0.0005 0.0009±0.0001























































Phenolic mass fractions are expressed as mean value±standard deviation (N=2) compared to the calculated mass fractions (given in parentheses). 
Δw=mass fraction difference between the calculated values and the values measured by LC-QQQ for given individual phenolic compounds
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p-coumaric acid, pHBA, quercetin and verbascoside. These bi-
oactives have a strong antimicrobial effect. Apigenin-7-O-glu-
coside has strong antifungal properties and may induce dam-
age to the fungal plasma membrane while inhibiting reactive 
oxidative species as the main mechanism of antifungal action 
in 14 different isolates of Candida spp. (43). The same research 
showed that the antimicrobial activity of apigenin-7-O-gluco-
side is stronger than that of apigenin. Caffeic acid has also been 
shown to potentially prevent Candida spp. growth, especial-
ly when applied in synergy with other antibiotics (44). In the 
study of Rauha et al. (45), naringenin was effective in prevent-
ing Staphylococcus aureus growth. Moreover, p-coumaric acid 
demonstrated strong antibacterial activity (46). For example, 
p-coumaric acid efficiently inhibited bacterial growth by in-
creasing the outer and plasma membrane permeability, thus 
diminishing their barrier function. Additionally, the findings of 
the same authors show that hydroxycinnamic acid can block 
bacterial replication, transcription and expression. pHBA was 
also found to be a strong antibacterial agent (31). Lastly, querce-
tin and verbascoside were added to this third mixture due to 
their strong bacteriostatic properties, which have been prov-
en mainly through research on Staphylococcus aureus and Es-
cherichia coli (47,48). The third infusion mixture was expected 
to exert antimicrobial activity with a wide range of actions. The 
proposed mixture design for this infusion is shown in Fig. 4c. 
Infusions were prepared from designed mixtures 1, 2 and 
3 by using the optimized water-based method, and their phe-
nolic content was analysed. The quantitative results of each 
individual polyphenol content in the designed infusion mix-
tures are presented in Table 2. For the majority of target phe-
nolic compounds, predicted mass fractions were consistent 
with or were within the acceptable range of those measured 
by the MS.
It should be noted that the employed design of functional 
products was based on previous scientific data on the biologi-
cal activity of the chosen phenolic compounds. As a result, the 
designed functional products may, theoretically, not induce the 
expected biological effects. Therefore, the biological evaluation 
of each infusion effect should be done. The findings of such 
experiments would provide comprehensive data on the true 
beneficial effects of these mixtures in the contexts of different 
health problems. Additionally, it would be interesting to de-
sign a new olive leaf infusion with beneficial effects on neuro-
degeneration processes. Recently, many scientific studies have 
focused on the effects of olive polyphenols on age-associat-
ed neurodegeneration processes (5). For example, it has been 
shown that these constituents interfere with the aggregation of 
peptides and proteins in the development of Alzheimer's and 
Parkinson's diseases and that they may protect cells against the 
age-associated functional derangement.
Finally, as polyphenols can influence the cytochrome fam-
ily of enzymes and can even act antagonistically upon each 
other (49), additional research on these interactions is nec-
essary for the safe preparation of an optimal functional olive 
leaf infusion.
CONCLUSIONS
We have presented a unique approach for the develop-
ment of three new functional infusions based on different 
mixtures of leaves of three olive cultivars, Istarska bjelica, Buža 
and Leccino. First, we determined the optimal conditions for 
infusion preparation: maceration for 15 min in water heated to 
100 °C. Phenolic characterization of the extracts showed that 
Istarska bjelica had the highest mass fraction of total phenols, 
with oleuropein as its dominant phenol. Although with the 
lowest mass fraction of phenols, Buža had the most diverse 
phenolic composition. Leccino had moderate mass fractions 
of all phenols, but the highest mass fraction of 3-hydroxytyro-
sol among the analysed cultivars. These data were statistically 
processed to design infusions that have specific biological ef-
fects. The first mixture was optimized to protect against cardi-
ovascular diseases and it consisted of 23.8 % Istarska bjelica, 
46.0 % Buža and 30.3 % Leccino cultivars. The second mix-
ture intended for the reduction of diabetes mellitus risk was 
composed of 29.9 % Istarska bjelica, 37.0 % Buža and 33.1 
% Leccino. The third infusion mixture was designed to exert 
antimicrobial activity, with optimal composition of 0.2 % Is-
tarska bjelica, 25.7 % Buža and 74.1 % Leccino. The approach 
presented in this paper can be further used to develop more 
functional products based on olive leaves. Also, new olive leaf 
cultivars with unique phenolic compositions could be added 
to enrich the infusions with other compounds that could pos-
sibly contribute to different biological activities.
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